JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 12 2073-2080
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welling, M. M.
Right arrow Articles by Calame, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welling, M. M.
Right arrow Articles by Calame, W.

Imaging of Bacterial Infections with 99mTc-Labeled Human Neutrophil Peptide-1

Mick M. Welling, Peter H. Nibbering, Akke Paulusma-Annema, Pieter S. Hiemstra, Ernest K.J. Pauwels and Wim Calame

Department of Radiology, Division of Nuclear Medicine
Departments of Infectious Diseases and Pulmonology, Leiden University Medical Center, Leiden
Hercules European Research Center, Barneveld, The Netherlands

Correspondence: For correspondence contact: Ernest K.J. Pauwels, Department of Radiology, Division of Nuclear Medicine, C4-Q, Leiden University Medical Center (LUMC), P.O. Box 9600, 2300 RC Leiden, The Netherlands.

ABSTRACT

This study was undertaken to evaluate whether 99mTc-labeled human neutrophil peptide (HNP)-1 can be used as a tracer for rapid visualization of bacterial infections. Methods: Mice were injected intramuscularly with 1 million Staphylococcus aureus or Klebsiella pneumoniae organisms and 5 min later were injected intravenously with 0.4 µg (0.8 MBq) 99mTc-HNP-1. At various intervals, detailed information about clearance and accumulation of this tracer at sites of infection and in various organs was obtained by scintigraphy. 99mTc-labeled immunoglobulin G(lgG), an established marker of infection and inflammation, was used for comparison. Results: After injection into S. aureus- or K. pneumoniae-injected mice, 99mTc-HNP-1 was rapidly removed from the circulation, mainly through the kidneys and bladder, with half-lives of 170 and 55 mm, respectively. Similar half-lives were observed for 99mTc-lgG in these animals. Visualization of foci with S. aureus or K. pneumoniae, as indicated by a ratio of 1.3 or higher between the targeted thigh muscle (containing bacteria) and the nontargeted (contralateral) thigh muscle (T/NT), was already achieved 5 min after injection of 99mTc-HNP-1. Similar T/NTs for 99mTc-lgG were obtained 4 h after injection of the tracer, indicating that imaging of foci of bacteria with 99mTc-HNP-1 is much faster than with 99mTc-lgG. To obtain insight into factors that contribute to accumulation of 99mTc-HNP-1 at sites of infection, the binding of this tracer to bacterial and leukocytes was assessed using a peritoneal infection model. Binding of 99mTc-HNP-1 to bacteria was approximately 1000 times higher than binding to leukocytes. Although the number of bacteria in the peritoneum was 1000-fold lower than the number of leukocytes, a significant correlation between binding of 99mTc-HNP-1 to bacteria on the one hand and accumulation of tracer on the other was still found, in contrast to 99mTc-lgG. Conclusion: 99mTc HNP-1 allows rapid visualization of bacterial infections. Binding of this tracer to bacteria most likely contributes significantly to the accumulation of 99mTc-HNP-1 at sites of infection.

Key Words: infection imaging • bacteria • 99mTc labeling • human neutrophil peptide-1




This article has been cited by other articles:


Home page
JNMHome page
J. E.M. van Eerd, M. Broekema, T. D. Harris, D. S. Edwards, W. J.G. Oyen, F. H.M. Corstens, and O. C. Boerman
Imaging of Infection and Inflammation with an Improved 99mTc-Labeled LTB4 Antagonist
J. Nucl. Med., September 1, 2005; 46(9): 1546 - 1551.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Tulchinsky and A. M. Peters
Leukocyte Receptor-Binding Radiopharmaceuticals for Infection and Inflammation Scintigraphy
J. Nucl. Med., May 1, 2005; 46(5): 718 - 721.
[Full Text] [PDF]


Home page
JNMHome page
M. S. Akhtar, J. Iqbal, M. A. Khan, J. Irfanullah, M. Jehangir, B. Khan, I. ul-Haq, G. Muhammad, M. A. Nadeem, M. S. Afzal, et al.
99mTc-Labeled Antimicrobial Peptide Ubiquicidin (29-41) Accumulates Less in Escherichia coli Infection than in Staphlococcus aureus Infection
J. Nucl. Med., May 1, 2004; 45(5): 849 - 856.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. M. Welling, A. Lupetti, H. S. Balter, S. Lanzzeri, B. Souto, A. M. Rey, E. O. Savio, A. Paulusma-Annema, E. K.J. Pauwels, and P. H. Nibbering
99mTc-Labeled Antimicrobial Peptides for Detection of Bacterial and Candida albicans Infections
J. Nucl. Med., May 1, 2001; 42(5): 788 - 794.
[Abstract] [Full Text]


Home page
JNMHome page
K. E. Britton, D. Wareham, K. K. Solanki, S. S. Das, M. M. Welling, P. H. Nibbering, A. Paulusma-Annema, P. S. Hiemstra, E. K.J. Pauwels, and W. Calame
Imaging of Bacterial Infections with 99mTc-Labeled Human Neutrophil Peptide-1
J. Nucl. Med., December 1, 2000; 41(12): 2099 - 2102.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.